Letter: bismuth, levofloxacin, amoxicillin, PPI quadruple therapy is not an effective first or second-line regimen in the presence of levofloxacin resistance--authors' reply.
Department of Gastroenterology, Hospital Universitario de La Princesa, IIS-IP and CIBEREHD, Madrid, Spain. javier.p.gisbert@gmail.com.
J P
JP
Gisbert
M
M
Romano
J
J
Molina-Infante
D000658:Amoxicillin / Q000627:therapeutic use*; D000863:Antacids / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001729:Bismuth / Q000627:therapeutic use*; D064098:Esomeprazole / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D064704:Levofloxacin / Q000627:therapeutic use*; D008297:Male; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*
D000863:Antacids; D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors; D064704:Levofloxacin; D000658:Amoxicillin; D064098:Esomeprazole; D001729:Bismuth